TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

30.30$ -0.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement PBLS
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – – 100.0%
– – – 100.0%
– – – 26,606.1%
– – – 7,876.4%
– – – 34,482.4%
– – – -34,382.4%
– – – 141.9%
– – – -35,448.0%
– – – -35,448.0%
– – – -34,905.4%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?